FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Search Results

Bumetanide Injection
Status: Currently in Shortage
»Date first posted: 12/13/2017
»Therapeutic Categories: Cardiovascular

Expand all

Fresenius Kabi USA, LLC (Revised 04/18/2024)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, .25 mg/1 mL (NDC 65219-570-04)	Unavailable	Backordered. Next release June 2024; Check wholesaler inventory	Delay in shipping of the drug
Injection, .25 mg/1 mL (NDC 65219-572-10)	Unavailable	Backordered. Next release May 2024; Check wholesalers for inventory	Delay in shipping of the drug

Hikma Pharmaceuticals USA, Inc. (Reverified 04/16/2024)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, .25 mg/1 mL (NDC 0641-6008-10)	Available	Additional lots are scheduled for manufacturing and will be available. Product will be made available as it is released.
Injection, .25 mg/1 mL (NDC 0641-6007-10)	Unavailable	Additional lots will be available in the February - March 2024 timeframe. Product will be made available as it is released.	Demand increase for the drug

MSN Laboratories Private Limited (Reverified 12/19/2023)

Company Contact Information:
Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01)	Available
Bumetanide, Injection, .25 mg/1 mL (NDC 72205-101-07)	Available
Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01)	Available
Bumetanide, Injection, .25 mg/1 mL (NDC 72205-102-07)	Available

Sagent Pharmaceuticals (Reverified 03/06/2024)

Company Contact Information:
866-625-1618

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Bumetanide, Injection, .25 mg/1 mL (NDC 70860-405-04)	Available
Bumetanide, Injection, .25 mg/1 mL (NDC 70860-406-10)	Available